Across TCGA pan-cancer cohorts, VN1R37P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of VN1R37P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where VN1R37P RNA is repressed in tumor relative to normal tissue. In most cancer types VN1R37P is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BRCA and KIRC are the cancer types where VN1R37P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VN1R37P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	−0.022	.002	6	view →
KIRC	All	II,III,IV	+0.016	.027	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: VN1R37P RNA expression & survival · all VN1R37P data types